Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-18-000416

Chief Medical Officer and SVP acquired 16,269 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stromatt Scott C Chief Medical Officer and SVP 2018-03-01 Option exercise +16,269 190,845 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Stromatt Scott C Chief Medical Officer and SVP 2018-03-01 Option exercise · Restricted Stock Unit −16,269 30,161 D: show line 2 in the form
Loading xslF345X03/stromatt_4.xml…